Alpine Biosciences

View Our Fact Sheet
Press Release: Alpine Biosciences Acquired by Oncothyreon
Chairman's Blog: Solving the impossible with science

Creating the Science We Imagined

At Alpine Biosciences, our team is committed to developing therapies for cancer and rare diseases using our expertise in next-generation nanoparticles and drug development. Our team won approval of the world’s first cancer immunotherapy, igniting excitement for an entirely new anti-cancer market potentially worth over $30 billion in the coming decade.

We believe that transforming the future of medicine takes vision and persistence.
At Alpine, we’re committed to exactly that.